Targeted Drug Delivery Devices: Optimizing Drug Administration Efficiency
Roots Analysis
Market research & consulting services in the pharma / biopharma, medical devices & contract manufacturing domains
The targeted drug delivery device market is witnessing robust growth, propelled by several key drivers including demand for biologics, rising prevalence of chronic diseases and the trend towards personalized medicine Till date, close to 40 targeted drug delivery devices are either commercialized or in clinical trials.
For detailed information:
Email: [email protected]
Competitive Landscape of Targeted Drug Delivery Device Market
According to Roots Analysis, the current market landscape features the presence of close to 40 targeted drug delivery devices. These devices have been assessed based on several parameters such as status of development, type of device, target organ, type of biologic delivered, type of therapy delivered, route of administration and target therapeutic area.
Within the targeted drug delivery devices industry, majority of the manufacturers are headquartered in North America (51%) followed by Europe and Asia-Pacific and Middle East and North Africa. Further, the targeted drug delivery devices market features the presence of small, mid-sized, large and very large companies engaged in manufacturing of targeted drug delivery devices across the globe. These companies are actively engaging in strategic initiatives such as rising clinical trials activities, inking publications and grants for targeted drug delivery devices.
Targeted Drug Delivery Devices Market Trends: Surge in the Number of Clinical Trials
In recent years, several pharmaceuticals / biopharmaceutical companies have invested extensively in order to evaluate the therapeutic viability and future potential of innovative pharmacological interventions. As more stem cell and gene therapies are getting approved by the regulatory authorities across the globe, the number of clinical trials across different regions is anticipated to increase as well. This can be attributed to the fact that these devices are in combination with the therapies holds great promise for enhancing treatment outcomes by maximizing efficacy, improving pharmacokinetics, addressing drug resistance, and paving the way for more personalized medicine approaches.
Targeted Drug Delivery Device Market Size
The global market opportunity for targeted drug delivery devices is estimated to be $427 million in 2026. In terms of the type of device, the market size for targeted drug delivery devices classified as cannula is anticipated to capture the highest share (90%) during the forecast period, till 2035. The market growth is primarily fueled by the ability of cannulas to deliver higher drug concentration directly at the targeted site, while reducing exposure to healthy tissues. Additionally, growing number of medical procedures and shift towards minimally invasive alternatives has led to the rise in the demand for cannulas, globally.
Regional Analysis: North America Holds the Largest Targeted Drug Delivery Devices Market Share
North America currently dominates the targeted drug delivery device market, accounting for 76% of the market value due to the region’s robust healthcare infrastructure, which facilitates the development and distribution of advanced drug delivery systems. Additionally, substantial investments in research and development from both public and private sectors is contributing to the market's growth potential.
All your Questions Related to Targeted Drug Delivery Device Market Answered in this Report
The Targeted Drug Delivery Device Market (2nd Edition), till 2035 report features extensive research of the current market landscape, market size, market forecast and future opportunities. The report answers many key questions related to this market. Click on the below link to know more about this emerging area of research.
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.